Fluence

Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.

Dr. Alex Camargo is a psychologist based in New York City and maintains a private practice in Manhattan. His work is heavily influenced by psychoanalytic and attachment theories where he works with clients to address anxiety, depression, life transitions and spiritual crises. In addition, he provides psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. He has also been employed to be a study therapist on a clinical trial investigating the impact of psilocybin on the treatment of body dysmorphic disorder at New York Psychiatric Institute. Dr. Camargo’s clinical training focused on providing mental health services in low-fee clinics and hospitals to traditionally underserved communities the Bronx, Brooklyn, and Nassau County.

Andrew is a psychedelic educator, harm reduction and integration coach, and certified mindfulness teacher. He has been working in some capacity with Fluence since before its inception, serving as an assisting trainer for early workshops and as a mentor for certificate program students. He also has over 15 years of experience working with various organizations on digital strategy, content, marketing, and technology, and has played a key role at Fluence in those areas through its early growth. Andrew has been practicing meditation since 2002, having studied mainly in the Tibetan Buddhist tradition before becoming interested in the clinical applications of mindfulness. He completed his training in Mindfulness-Based Stress Reduction with the Centre for Mindfulness Studies in 2018 and has been educating clinicians, therapists and the general public about psychedelics and their therapeutic applications since 2017. Prior to his work with Fluence he established the Psychedelic Harm Reduction and Integration program at Mindspace, and was the Director of Programming and Content at Numinus. He completed MAPS’s MDMA Therapy for PTSD training program in 2021 and is also the co-director of Plant Parenthood, a community organization that looks at the intersection of family, parenting, and the intentional therapeutic use of psychedelics. He came on board officially in October 2022 as Fluence’s VP of Marketing and Strategy.